Should Investors worry? Yes : Citi strategist - The Globe and Mail theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
Author Bio
Taylor Carmichael is a former attorney and filmmaker. He s the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.
Shares of
Trillium Therapeutics (NASDAQ:TRIL) skyrocketed last year. After selling for $1.17 on the first trade in January, the shares clocked out at $14.71 on the last trade in December. This amazing run made Trillium a 13-bagger, and one of the strongest performers in the healthcare space in 2020. What caused this magnificent run?
In this clip from
Pfizer is investing US$25m in a US developer of live biotherapeutics, Vedanta Biosciences; that project is one of four investments, totaling US$120m, made by Pfizer in the second half of 2020 under its breakthrough growth program focused on clinical stage biotech companies of potential future strategic interest to the pharma giant.
These updates are republished press releases and communications from members of the Science|Business Network
Pfizer invests $120M in four biotechnological innovation companies
Pfizer Inc. today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI). Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to help ensure the continuity of promising clinical development programs of potential future strategic interest to Pfizer.
Pfizer’s initial PBGI investments include:
$10 million in Vancouver, BC-based ESSA Pharma (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer.